Brittenham Marissa 4
4 · Surgery Partners, Inc. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Brittenham Marissa
Chief Strategy Officer
Transactions
- Award
Common Stock
2025-01-31+25,110→ 64,878 total
Footnotes (1)
- [F1]Shares issued based on performance vesting criteria for the three-year period ended December 31, 2024 under performance stock unit awards granted to the Reporting Person on February 1, 2022. Shares vested immediately upon certification by the Board on January 31, 2025.